Tradestie Institutional Equity Comparison Engine

SANA vs ANL โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

SANA Overall Edge

SANA Captures Institutional Edge (2โ€“1 Pillars ยท 3โ€“5 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Sana Biotechnology, Inc. Common Stock (SANA) driven by superior Growth & Margin, Options & Structure while ANL counters with relative strength in Momentum & Technical. Fundamentally, SANA trades at N/M Forward P/E with 0.0% operating margin (+0.0% YoY revenue) versus ANL at N/M Forward P/E and -123.5% operating margin (+178.1% YoY). In options structure, SANA sits in BREAKDOWN (4th %ile IV; Dealer Gamma Walls on Pro) against ANL sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).

Valuation Winner Tie
SANA N/M vs ANL N/M Fwd P/E
Growth & Margin Winner SANA
Op Margin 0.0% vs -123.5% ยท YoY +0.0% vs +178.1%
Momentum & Technical Winner ANL
1Y -48.6% vs +564.2% ยท 52W Pos 1% vs 56%
Options & Structure Winner SANA
BREAKDOWN (4th %ile IV) vs UNCLASSIFIED (N/A IV)
SANA NASDAQ
Sana Biotechnology, Inc. Common Stock
Biological Products, (No Disgnostic Substances)
$1.88
-6.93% 1D
Market Cap $605.3M
1M Return -17.18%
1Y Return -48.63%
Forward P/E N/M
Unified AI Score
44.3 / 100 HOLD
Tech 33.0 Fund 51.0 Flow 66.0 Mom 60.0
ANL US Equity
ANL
Institutional Equity
$10.03
-5.47% 1D
Market Cap $683.3M
1M Return -9.07%
1Y Return +564.24%
Forward P/E N/M
Unified AI Score
48.3 / 100 HOLD
Tech 48.0 Fund 52.0 Flow 50.0 Mom 50.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: SANA -48.63% ANL +564.24% Spread: +612.87 pp (ANL Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
SANA TTM Op. Margin: 0.0% ANL TTM Op. Margin: -123.5%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on SANA vs ANL. Trailing 12-month operating profitability (SANA 0.0% vs ANL -123.5%) and valuation multiples (SANA N/M vs ANL N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: SANA (3) vs ANL (5)
Institutional Metric SANA ANL Criterion Row Winner
Market Capitalization Scale $605.3M $683.3M Larger Scale ANL
Trailing P/E Ratio Valuation N/M N/M Lower Multiple Tie
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth +0.0% +178.1% Higher Growth ANL
Operating Margin (TTM) Profitability 0.0% -123.5% Higher Margin SANA
Net Profit Margin Profitability 0.0% -124.8% Higher Margin SANA
Return on Equity (ROE) Capital Efficiency -79.5% -20.2% Higher ROE ANL
52-Week Range Position Momentum 1% ($2โ€“$5) 56% ($1โ€“$17) Stronger Trend ANL
Beta / 30D Volatility Risk Regime 1.82ฮฒ ยท 78% Vol 2.64ฮฒ ยท 81% Vol Lower Realized Risk SANA
Unified Institutional Score Composite Signal 44.3 / 100 (HOLD) 48.3 / 100 (HOLD) Higher Composite ANL

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full SANA vs ANL Buy Guide
SANA BREAKDOWN
57d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 4th %ile
IV Regime Compressed (<25th %ile)
Live SANA Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
ANL UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live ANL Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither SANA nor ANL registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.